Literature DB >> 10084173

Polyarthritis following intravesical BCG immunotherapy. Report of a case and review of 26 cases in the literature.

G Clavel1, F Grados, G Cayrolle, R Bellony, I Leduc, B Lafont, J P Ducroix, P Fardellone.   

Abstract

OBJECTIVE: To delineate the characteristics of aseptic arthritis induced by intravesical BCG immunotherapy.
METHODS: Review of a personal case and 26 cases from the literature.
RESULTS: Mean number of intravesical BCG instillations at arthritis onset was five. Arthritis onset was within two weeks of the last instillation in 90% of cases. Half the patients had fever and half had conjunctivitis or uveitis. Symmetric polyarthritis was the most common pattern (n = 19), followed by oligoarthritis (n = 7). One patient had monoarthritis. The main targets were the knees (81%), ankles (48%), and wrists (40%). Twenty-six percent of patients reported back pain and 11% had sacroiliitis manifesting as pain or radiological changes. Mean erythrocyte sedimentation rate was 89 mm/h and mean C-reactive protein was greater than 70 mg/l. HLA B27 was positive in 56% of cases. Joint fluid usually exhibited inflammatory properties with polymorphonuclear neutrophils as the predominant cell type. Synovial membrane biopsy showed nonspecific synovitis in the six patients who had this investigation. Nonsteroidal antiinflammatory therapy was effective in 75% of cases. Three of the six patients given isoniazid and/or rifampin responded to this treatment.
CONCLUSION: Although arthritis induced by intravesical BCG immunotherapy is more often polyarticular than oligoarticular, it shares many features with reactive arthritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084173

Source DB:  PubMed          Journal:  Rev Rhum Engl Ed        ISSN: 1169-8446


  3 in total

1.  Bilateral uveitis after intravesical BCG immunotherapy for bladder carcinoma.

Authors:  M Wertheim; N Astbury
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

Review 2.  Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review.

Authors:  Elisa Tinazzi; Vincenzo Ficarra; Sara Simeoni; Walter Artibani; Claudio Lunardi
Journal:  Rheumatol Int       Date:  2005-10-12       Impact factor: 2.631

3.  Discrimination between normal and glaucomatous eyes with visual field and scanning laser polarimetry measurements.

Authors:  R Lauande-Pimentel; R A Carvalho; H C Oliveira; D C Gonçalves; L M Silva; V P Costa
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.